The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Gastric cancer—molecular and clinical dimensions
Open accessAbstract
Gastric cancer imposes a considerable health burden around the globe despite its declining incidence. The disease is often diagnosed in advanced stages and is associated with a poor prognosis for patients. An in-depth understanding of the molecular underpinnings of gastric cancer has lagged behind many other cancers of similar incidence and morbidity, owing to our limited knowledge of germline susceptibility traits for risk and somatic drivers of progression (to identify novel therapeutic targets). A few germline (PLCE1) and somatic (ERBB2, ERBB3, PTEN, PI3K/AKT/mTOR, FGF, TP53, CDH1 and MET) alterations are emerging and some are being pursued clinically. Novel somatic gene targets (ARID1A, FAT4, MLL and KMT2C) have also been identified and are of interest. Variations in the therapeutic approaches dependent on geographical region are evident for localized gastric cancer—differences that are driven by preferences for the adjuvant strategies and the extent of surgery coupled with philosophical divides. However, greater uniformity in approach has been noted in the metastatic cancer setting, an incurable condition. Having realized only modest successes, momentum is building for carrying out more phase III comparative trials, with some using biomarker-based patient selection strategies. Overall, rapid progress in biotechnology is improving our molecular understanding and can help with new drug discovery. The future prospects are excellent for defining biomarker-based subsets of patients and application of specific therapeutics. However, many challenges remain to be tackled. Here, we review representative molecular and clinical dimensions of gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
Macdonald, J. S., Smalley, S. R., Benedetti, J., Hundahl, S. A., Estes, N. C., Stemmermann, G. N., Haller, D. G., Ajani, J. A., Gunderson, L. L., Jessup, J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010187 · Cited by 3,475
Self-citationSnail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Sakuramoto, S., Sasako, M., Yamaguchi, T., Kinoshita, T., Fujii, M., Nashimoto, A., Furukawa, H., Nakajima, T., Ohashi, Y., Imamura, H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072252 · Cited by 2,517
Ychou, M., Boige, V., Pignon, J.-P., Conroy, T., Bouché, O., Lebreton, G., Ducourtieux, M., Bedenne, L., Fabre, J.-M., Saint-Aubert, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0597 · Cited by 2,086
Van Cutsem, E., Moiseyenko, V. M., Tjulandin, S., Majlis, A., Constenla, M., Boni, C., Rodrigues, A., Fodor, M., Chao, Y., Voznyi, E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8429 · Cited by 1,926
Self-citationKoizumi, W., Narahara, H., Hara, T., Takagane, A., Akiya, T., Takagi, M., Miyashita, K., Nishizaki, T., Kobayashi, O., Takiyama, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70035-4 · Cited by 1,847
Bang, Y.-J., Kim, Y.-W., Yang, H.-K., Chung, H. C., Park, Y.-K., Lee, K. H., Lee, K.-W., Kim, Y. H., Noh, S.-I., Cho, J. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61873-4 · Cited by 1,705
E-cadherin germline mutations in familial gastric cancer
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., & Reeve, A. E. (1998) · Nature · doi:10.1038/32918 · Cited by 1,656
Sasako, M., Sakuramoto, S., Katai, H., Kinoshita, T., Furukawa, H., Yamaguchi, T., Nashimoto, A., Fujii, M., Nakajima, T., & Ohashi, Y. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5908 · Cited by 1,434
Engelman, J. A., Chen, L., Tan, X., Crosby, K., Guimaraes, A. R., Upadhyay, R., Maira, M., McNamara, K., Perera, S. A., Song, Y., et al. (2008) · Nature Medicine · doi:10.1038/nm.1890 · Cited by 1,330
TGFβ: the molecular Jekyll and Hyde of cancer
Bierie, B., & Moses, H. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1926 · Cited by 1,267
PTEN and the PI3-Kinase Pathway in Cancer
Chalhoub, N., & Baker, S. J. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092311 · Cited by 1,245
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Ohtsu, A., Shah, M. A., Van Cutsem, E., Rha, S. Y., Sawaki, A., Park, S. R., Lim, H. Y., Yamada, Y., Wu, J., Langer, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.2236 · Cited by 1,110
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Takaishi, S., Okumura, T., Tu, S., Wang, S. S. W., Shibata, W., Vigneshwaran, R., Gordon, S. A. K., Shimada, Y., & Wang, T. C. (2009) · Stem Cells · doi:10.1002/stem.30 · Cited by 1,039
SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein
Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M., & Hatakeyama, M. (2002) · Science · doi:10.1126/science.1067147 · Cited by 1,029
Molina, M. A., Codony‐Servat, J., Albanell, J., Rojo, F., Arribas, J., & Baselga, J. M. (2001) · PubMed · Cited by 946
Smalley, S. R., Benedetti, J. K., Haller, D. G., Hundahl, S. A., Estes, N. C., Ajani, J. A., Gunderson, L. L., Goldman, B., Martenson, J. A., Jessup, J. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.7136 · Cited by 842
Self-citationLordick, F., Kang, Y.-K., Chung, H.-C., Salman, P., Oh, S. C., Bodoky, G., Kurteva, G., Volovat, C., Moiseyenko, V. M., Gorbunova, V., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70102-5 · Cited by 833
Lee, J., Lim, D. H., Kim, S., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Choi, M. G., Sohn, T. S., Noh, J. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1953 · Cited by 803
Self-citationBenefit of Adjuvant Chemotherapy for Resectable Gastric Cancer: A Meta-analysis
(2010) · JAMA · doi:10.1001/jama.2010.534 · Cited by 794
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Wang, K., Kan, J., Yuen, S. T., Shi, S. T., Chu, K. M., Law, S., Chan, T. L., Kan, Z., Chan, A. S. Y., Tsui, W. Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.982 · Cited by 771
The two faces of transforming growth factor β in carcinogenesis
Roberts, A. B., & Wakefield, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633291100 · Cited by 747
Waddell, T., Chau, I., Cunningham, D., Gonzalez, D., Okines, A. F. C., Wotherspoon, A., Saffery, C., Middleton, G., Wadsley, J., Ferry, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70096-2 · Cited by 725
Carcinogenesis of Helicobacter pylori
Correa, P., & Houghton, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.026 · Cited by 705
Zhou, J., Wulfkuhle, J., Zhang, H., Gu, P., Yang, Y., Deng, J., Margolick, J. B., Liotta, L. A., Petricoin, E., & Zhang, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702596104 · Cited by 698
Kang, J. H., Lee, S. I., Lim, D. H., Park, K.-W., Oh, S. Y., Kwon, H.-C., Hwang, I. G., Lee, S.-C., Nam, E., Shin, D. B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.4585 · Cited by 660
Self-citationDeng, N., Goh, L. K., Wang, H., Das, K., Tao, J., Tan, I. B., Zhang, S., Lee, M., Wu, J., Lim, K. H., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301839 · Cited by 645
Recent patterns in gastric cancer: A global overview
Bertuccio, P., Chatenoud, L., Levi, F., Praud, D., Ferlay, J., Negri, E., Malvezzi, M., & La Vecchia, C. (2009) · International Journal of Cancer · doi:10.1002/ijc.24290 · Cited by 624
Zang, Z. J., Cutcutache, I., Poon, S. L., Zhang, S. L., McPherson, J. R., Tao, J., Rajasegaran, V., Heng, H. L., Deng, N., Gan, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2246 · Cited by 616
Thuss-Patience, P. C., Kretzschmar, A., Bichev, D., Deist, T., Hinke, A., Breithaupt, K., Dogan, Y., Gebauer, B., Schumacher, G., & Reichardt, P. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.002 · Cited by 612
Ajani, J. A., Rodriguez, W., Bodoky, G., Moiseyenko, V., Lichinitser, M., Gorbunova, V., Vynnychenko, I., Garin, A., Lang, I., & Falcon, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4706 · Cited by 550
Self-citationKorkaya, H., Kim, G.-I., Davis, A., Malik, F., Henry, N. L., Ithimakin, S., Quraishi, A. A., Tawakkol, N., D'Angelo, R., Paulson, A. K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.014 · Cited by 538
Brandt, S., Kwok, T., Hartig, R., König, W., & Backert, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409873102 · Cited by 534
Nagy, P., Friedländer, E., Tanner, M., Kapanen, A. I., Carraway, K. L., Isola, J., & Jovin, T. M. (2005) · Cancer Research · doi:10.1158/0008-5472.473.65.2 · Cited by 523
Signaling networks assembled by oncogenic EGFR and c-Met
Guo, A., Villén, J., Kornhauser, J., Lee, K. A., Stokes, M. P., Rikova, K., Possemato, A., Nardone, J., Innocenti, G., Wetzel, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707270105 · Cited by 505
Eichhorn, P. J. A., Gili, M., Scaltriti, M., Serra, V., Guzman, M., Nijkamp, W., Beijersbergen, R. L., Valero, V., Seoane, J., Bernards, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1740 · Cited by 499
Abnet, C. C., Freedman, N. D., Hu, N., Wang, Z., Yu, K., Shu, X.-O., Yuan, J.-M., Zheng, W., Dawsey, S. M., Dong, L. M., et al. (2010) · Nature Genetics · doi:10.1038/ng.649 · Cited by 487
Smolen, G. A., Sordella, R., Muir, B., Mohapatra, G., Barmettler, A., Archibald, H., Kim, W. J., Okimoto, R. A., Bell, D. W., Sgroi, D. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508776103 · Cited by 485
Matsumoto, Y., Marusawa, H., Kinoshita, K., Endo, Y., Kou, T., Morisawa, T., Azuma, T., Okazaki, I.-M., Honjo, T., & Chiba, T. (2007) · Nature Medicine · doi:10.1038/nm1566 · Cited by 479
Van Cutsem, E., de Haas, S., Kang, Y.-K., Ohtsu, A., Tebbutt, N. C., Ming Xu, J., Peng Yong, W., Langer, B., Delmar, P., Scherer, S. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.9824 · Cited by 477
Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells
Shattuck, D. L., Miller, J. K., Carraway, K. L., & Sweeney, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5962 · Cited by 473
Garrett, J. T., Olivares, M. G., Rinehart, C., Granja-Ingram, N. D., Sánchez, V., Chakrabarty, A., Dave, B., Cook, R. S., Pao, W., McKinely, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016140108 · Cited by 467
Murata-Kamiya, N., Kurashima, Y., Teishikata, Y., Yamahashi, Y., Saito, Y., Higashi, H., Aburatani, H., Akiyama, T., Peek, R. M., Azuma, T., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210251 · Cited by 466
Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer
Ooi, C. H., Ivanova, T., Wu, J., Lee, M., Tan, I. B., Tao, J., Ward, L., Koo, J. H., Gopalakrishnan, V., Zhu, Y., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000676 · Cited by 447
Self-citationCommon and Distinct Elements in Cellular Signaling via EGF and FGF Receptors
Schlessinger, J. (2004) · Science · doi:10.1126/science.1105396 · Cited by 443
Lennerz, J. K., Kwak, E. L., Ackerman, A., Michael, M., Fox, S. B., Bergethon, K., Lauwers, G. Y., Christensen, J. G., Wilner, K. D., Haber, D. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.4928 · Cited by 433
Roles of TGF-β family signaling in stem cell renewal and differentiation
Watabe, T., & Miyazono, K. (2009) · Cell Research · doi:10.1038/cr.2008.323 · Cited by 428
Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations
Huntsman, D. D., Carneiro, F., Lewis, F. R., MacLeod, P., Hayashi, A., Monaghan, K. G., Maung, R., Seruca, R., Jackson, C. E., & Caldas, C. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442504 · Cited by 416
Wang, L.-D., Zhou, F.-Y., Li, X.-M., Sun, L.-D., Song, X., Jin, Y., Li, J.-M., Kong, G.-Q., Qi, H., Cui, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.648 · Cited by 415
Self-citationGenetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer
The Study Group of Millennium Genome Project for Cancer (2008) · Nature Genetics · doi:10.1038/ng.152 · Cited by 389
Helicobacter pylori: the African enigma.
Holcombe, C. (1992) · Gut · doi:10.1136/gut.33.4.429 · Cited by 378
Tan, I. B., Ivanova, T., Lim, K. H., Ong, C. W., Deng, N., Lee, J., Tan, S. H., Wu, J., Lee, M. H., Ooi, C. H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.042 · Cited by 357
Self-citationTargeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
Markman, B., Dienstmann, R., & Tabernero, J. (2010) · Oncotarget · doi:10.18632/oncotarget.188 · Cited by 355
E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric Carcinomas
Tamura, G. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.569 · Cited by 352
Oncogenic ERBB3 mutations in human cancers.
Jaiswal, B. S., Kljavin, N. M., Stawiski, E. W., Chan, E., Parikh, C., Durinck, S., Chaudhuri, S., Pujara, K., Guillory, J., Edgar, K. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.012 · Cited by 350
Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer
Cho, J. Y., Lim, J. Y., Cheong, J. H., Park, Y.-Y., Yoon, S.-L., Kim, S. M., Kim, S.-B., Kim, H., Hong, S. W., Park, Y. N., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2180 · Cited by 349
Self-citationBone marrow-derived mesenchymal stem cells and the tumor microenvironment
Bergfeld, S. A., & DeClerck, Y. A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9222-7 · Cited by 345
Peek, R. M., Moss, S. F., Wang, S., Holt, P. R., Tham, K. T., Blaser, M. J., Perez-Perez, G. I., Miller, G. G., & Atherton, J. C. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.12.863 · Cited by 336
Shi, Y., Hu, Z., Wu, C., Dai, J., Li, H., Dong, J., Wang, M., Miao, X., Zhou, Y., Lu, F., et al. (2011) · Nature Genetics · doi:10.1038/ng.978 · Cited by 276
Arcaro, A., & Guerreiro, A. (2007) · Current Genomics · doi:10.2174/138920207782446160 · Cited by 269
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
Li, Y., Li, A., Glas, M., Lal, B., Ying, M., Sang, Y., Xia, S., Trageser, D., Guerrero-Cázares, H., Eberhart, C. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016912108 · Cited by 266
Meyer-ter-Vehn, T., Covacci, A., Kist, M., & Pahl, H. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000959200 · Cited by 249
Takahashi, Y., Cleary, K. R., Mai, M., Kitadai, Y., Bucana, C. D., & Ellis, L. M. (1996) · PubMed · Cited by 244
Mueller, D., Tegtmeyer, N., Brandt, S., Yamaoka, Y., De Poire, E., Sgouras, D., Wessler, S., Torres, J., Smolka, A., & Backert, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61143 · Cited by 239
Cancer therapy: can the challenge be MET?
Corso, S., Comoglio, P. M., & Giordano, S. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.04.005 · Cited by 238
Tsugawa, H., Suzuki, H., Saya, H., Hatakeyama, M., Hirayama, T., Hirata, K., Nagano, O., Matsuzaki, J., & Hibi, T. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.014 · Cited by 231
H. pylori infection and gastric cancer: State of the art
CONTEDUCA, V., SANSONNO, D., LAULETTA, G., RUSSI, S., INGRAVALLO, G., & DAMMACCO, F. (2013) · International Journal of Oncology · doi:10.3892/ijo.2012.1701 · Cited by 231
Molecular biology of gastric cancer*
ELRIFAI, W., & POWELL, S. (2002) · Seminars in Radiation Oncology · doi:10.1053/srao.2002.30815 · Cited by 231
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma
Kim, S. S., Ruiz, V. E., Carroll, J. D., & Moss, S. F. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.07.014 · Cited by 212
Suzuki, M., Mimuro, H., Suzuki, T., Park, M., Yamamoto, T., & Sasakawa, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051027 · Cited by 211
Lu, Y., Zi, X., & Pollak, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.11445 · Cited by 208
Takaishi, S., Okumura, T., & Wang, T. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2603 · Cited by 206
ZAMBON, C., BASSO, D., NAVAGLIA, F., BELLUCO, C., FALDA, A., FOGAR, P., GRECO, E., GALLO, N., RUGGE, M., & DIMARIO, F. (2005) · Cytokine · doi:10.1016/j.cyto.2004.10.013 · Cited by 205
Singh, B. N., Fu, J., Srivastava, R. K., & Shankar, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027306 · Cited by 197
Lee, K., Inoue, M., Otani, T., Iwasaki, M., Sasazuki, S., & Tsugane, S. (2006) · International Journal of Cancer · doi:10.1002/ijc.21664 · Cited by 195
Regulation of p53 Tumor Suppressor by Helicobacter pylori in Gastric Epithelial Cells
Wei, J., Nagy, T. A., Vilgelm, A., Zaika, E., Ogden, S. R., Romero–Gallo, J., Piazuelo, M. B., Correa, P., Washington, M. K., El–Rifai, W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.018 · Cited by 190
Rad, R., Prinz, C., Neu, B., Neuhofer, M., Zeitner, M., Voland, P., Becker, I., Schepp, W., & Gerhard, M. (2003) · The Journal of Infectious Diseases · doi:10.1086/376458 · Cited by 188
Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer
Zouridis, H., Deng, N., Ivanova, T., Zhu, Y., Wong, B., Huang, D., Wu, Y. H., Wu, Y., Tan, I. B., Liem, N., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004504 · Cited by 186
Byun, D., Cho, K., Ryu, B., Lee, M., Park, J., Chae, K., Kim, H., & Chi, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.10962 · Cited by 184
MET Activation Mediates Resistance to Lapatinib Inhibition of HER2 -Amplified Gastric Cancer Cells
Chen, C.-T., Kim, H., Liska, D., Gao, S., Christensen, J. G., & Weiser, M. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0754 · Cited by 178
Graham, D. Y., & Yamaoka, Y. (1998) · Helicobacter · doi:10.1046/j.1523-5378.1998.08031.x · Cited by 172
Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule?
Saeki, N., Gu, J., Yoshida, T., & Wu, X. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3169 · Cited by 170
Lang, S. A., Gaumann, A., Koehl, G. E., Seidel, U., Bataille, F., Klein, D., Ellis, L. M., Bolder, U., Hofstaedter, F., Schlitt, H., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22442 · Cited by 169
MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors
Cepero, V., Sierra, J. R., Corso, S., Ghiso, E., Casorzo, L., Perera, T., Comoglio, P. M., & Giordano, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0436 · Cited by 167
Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
Zhang, X. L., Yang, Y. S., Xu, D. P., Qu, J. H., Guo, M. Z., Gong, Y., & Huang, J. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0142-z · Cited by 165
Wu, Y., Grabsch, H., Ivanova, T., Tan, I. B., Murray, J., Ooi, C. H., Wright, A. I., West, N. P., Hutchins, G. G. A., Wu, J., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301373 · Cited by 163
Self-citationGastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer
Cui, L., Zhang, X., Ye, G., Zheng, T., Song, H., Deng, H., Xiao, B., Xia, T., Yu, X., Le, Y., et al. (2013) · Cancer · doi:10.1002/cncr.27903 · Cited by 162
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Valladares-Ayerbes, M., Reboredo, M., Medina-Villaamil, V., Iglesias-Díaz, P., Lorenzo-Patiño, M. J., Haz, M., Santamarina, I., Blanco, M., Fernández-Tajes, J., Quindós, M., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-186 · Cited by 161
Chang, Y., Wu, M., Lin, J.-T., Sheu, B., Muta, T., Inoue, H., & Chen, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005199 · Cited by 158
Yu, G., Wang, J., Chen, Y., Wang, X., Pan, J., Li, G., Jia, Z., Li, Q., Yao, J. C., & Xie, K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2138 · Cited by 156
METExpression and Amplification in Patients with Localized Gastric Cancer
Janjigian, Y. Y., Tang, L. H., Coit, D. G., Kelsen, D. P., Francone, T. D., Weiser, M. R., Jhanwar, S. C., & Shah, M. A. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1080 · Cited by 151
Peterson, A. J., Menheniott, T. R., O’Connor, L., Walduck, A. K., Fox, J. G., Kawakami, K., Minamoto, T., Ong, E. K., Wang, T. C., Judd, L. M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.043 · Cited by 148
Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges
Stern, H. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3001539 · Cited by 145
Adjuvant Therapy in Gastric Cancer
Lim, L., Michael, M., Mann, G. B., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.593 · Cited by 143
Deng, H., Guo, Y., Song, H., Xiao, B., Sun, W., Liu, Z., Yu, X., Xia, T., Cui, L., & Guo, J. (2013) · Gene · doi:10.1016/j.gene.2012.12.103 · Cited by 143
Pinto, C., Fabio, F. D., Barone, C. A., Siena, S., Falcone, A., Cascinu, S., Llimpe, F. L. R., Stella, G. M., Schinzari, G., Artale, S. A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605319 · Cited by 142
Maesawa, C., Tamura, G., Suzuki, Y. A., Ogasawara, S., Sakata, K., Kashiwaba, M., & Satodate, R. (1995) · The Journal of Pathology · doi:10.1002/path.1711760307 · Cited by 141
Circulating miR-17-5p and miR-20a: Molecular markers for gastric cancer
Xu, W. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.828 · Cited by 141
Bachleitner‐Hofmann, T., Sun, M. Y., Chen, C., Tang, L. H., Song, L., Zeng, Z., Shah, M. A., Christensen, J. G., Rosen, N. X., Solit, D. B., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0374 · Cited by 136
Kim, H. K., Choi, I. J., Kim, C. G., Kim, H. S., Oshima, A., Michalowski, A., & Green, J. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016694 · Cited by 135
Saeki, N., Saito, A., Choi, I. J., Matsuo, K., Ohnami, S., Totsuka, H., Chiku, S., Kuchiba, A., Lee, Y.-S., Yoon, K., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.058 · Cited by 133
Hedgehog Signal Activation in Gastric Pit Cell and in Diffuse-Type Gastric Cancer
Fukaya, M., Isohata, N., Ohta, H., Aoyagi, K., Ochiya, T., Saeki, N., Yanagihara, K., Nakanishi, Y., Taniguchi, H., Sakamoto, H., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.008 · Cited by 130
Molecular cancer therapy: Can our expectation be MET?
Migliore, C., & Giordano, S. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.01.022 · Cited by 128
MAPKs: function, regulation, role in cancer and therapeutic targeting
Dhanasekaran, D. N., & Johnson, G. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210395 · Cited by 124
Cancer Stem Cells and the Ontogeny of Lung Cancer
Peacock, C. D., & Watkins, D. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2702 · Cited by 121
Gene Expression Profile Predicts Patient Survival of Gastric Cancer After Surgical Resection
Chen, C., Lin, J.-J., Chen, J. J. W., Lee, P., Yang, C., Kuo, M., Chang, K., & Hsieh, F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.2253 · Cited by 121
Kim, J. W., Kim, H., Im, S., Kang, S., Hur, H.-S., Yoon, Y., Oh, D., Kim, J. H., Lee, D. S., Kim, T., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.07.018 · Cited by 119
Immunohistochemical detection of K-sam protein in stomach cancer.
Hattori, Y., Itoh, H., Uchino, S., Hosokawa, K., Ochiai, A., Ino, Y., Ishii, H., Sakamoto, H., Yamaguchi, N., Yanagihara, K., et al. (1996) · PubMed · Cited by 119
Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer
Ivanova, T., Zouridis, H., Wu, Y., Cheng, L. L., Tan, I. B., Gopalakrishnan, V., Ooi, C.-H., Lee, J., Qin, L., Wu, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301113 · Cited by 114
Self-citationCrone, S. G., Skanderup, A. J., Federspiel, B., Bardram, L., Krogh, A., Lund, A. H., & Friis-Hansen, L. J. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-71 · Cited by 114
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition
Corso, S., Ghiso, E., Cepero, V., Sierra, J. R., Migliore, C., Bertotti, A., Trusolino, L., Comoglio, P. M., & Giordano, S. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-121 · Cited by 108
Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast Cancer
Nahta, R. (2012) · ISRN Oncology · doi:10.5402/2012/428062 · Cited by 106
The role of microRNAs in cancers of the upper gastrointestinal tract
Song, S., & Ajani, J. A. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.210 · Cited by 106
Self-citationHe, X., Shao, Y., Li, X., Xu, W., Chen, G., Sun, H., Xu, H., Xu, X., Tang, D., Zheng, X., et al. (2012) · FEBS Journal · doi:10.1111/febs.12013 · Cited by 104
Cancer Stem Cells: A Novel Paradigm for Cancer Prevention and Treatment
Subramaniam, D. S., Ramalingam, S., Houchen, C. W., & Anant, S. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791330954 · Cited by 103
Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer
Cai, H., Yuan, Y., Hao, Y., Guo, T., Wei, X., & Zhang, Y. (2013) · Medical Oncology · doi:10.1007/s12032-012-0452-0 · Cited by 101
Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer
Wang, M., Li, C., Yu, B., Su, L., Li, J., Ju, J., Yu, Y., Gu, Q., Zhu, Z., & Liu, B. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0733-6 · Cited by 99
Wu, X., Ajani, J. A., Gu, J. H., Chang, D. W., Tan, W., Hildebrandt, M. A. T., Huang, M., Wang, K. K., & Hawk, E. T. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0276 · Cited by 98
Self-citationInhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells
Browne, B. C., Crown, J. P., Venkatesan, N., Duffy, M. J., CLYNES, M. M., Slamon, D. J., & O’Donovan, N. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq349 · Cited by 98
Li, T., Lu, Y., Zhao, X., Guo, H. Q., Liu, C., Li, H., Zhou, L., Han, Y., Wu, K., Nie, Y., et al. (2013) · Oncogene · doi:10.1038/onc.2012.637 · Cited by 97
Bartchewsky, W., Martini, M. R., Masiero, M., Squassoni, A. C., Alvarez, M. C., Ladeira, M. S. P., Salvadori, D. M. F., Trevisan, M. S., Pedrazzoli, J., & Ribeiro, M. L. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802530853 · Cited by 94
Lymphangiogenesis and biological behavior in pancreatic carcinoma and other pancreatic tumors
Wang, Z., Wu, J., Li, G., Zhang, X., Tong, M.-M., Wu, Z., & Liu, Z. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.745 · Cited by 93
Anti-HER agents in gastric cancer: from bench to bedside
Fornaro, L., Lucchesi, M., Caparello, C., Vasile, E., Caponi, S., Ginocchi, L., Masi, G., & Falcone, A. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.81 · Cited by 91
Voutsadakis, I. A. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-67 · Cited by 88
Zheng, L., Pu, J., Qi, T., Meng, Q., Li, D., Xiang, X., Huang, K., & Tong, Q. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0534 · Cited by 86
Tan, D. S. W., Gerlinger, M., Teh, B. T., & Swanton, C. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.019 · Cited by 85
Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells
Cao, W., Fan, R., Wang, L., Cheng, S., Li, H., Jiang, J., Geng, M., Ye-ning, J., & Wu, Y. (2012) · Tumor Biology · doi:10.1007/s13277-012-0632-8 · Cited by 85
TNF‐α‐inducing protein, a carcinogenic factor secreted from H. pylori , enters gastric cancer cells
Suganuma, M., Yamaguchi, K., Ono, Y., Matsumoto, H., Hayashi, T., Ogawa, T., Imai, K., Kuzuhara, T., Nishizono, A., & Fujiki, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23484 · Cited by 84
Akiyoshi, S., Fukagawa, T., Ueo, H., Ishibashi, M., Takahashi, Y., Fabbri, M., Sasako, M., Maehara, Y., Mimori, K., & Mori, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.326 · Cited by 83
Hatakeyama, M. (2008) · Oncogene · doi:10.1038/onc.2008.353 · Cited by 83
Hatakeyama, M. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00085-0 · Cited by 83
Oliner, K. S., Tang, R., Anderson, A., Lan, Y., Iveson, T. J., Donehower, R. C., Jiang, Y., Dubey, S., & Loh, E. Y. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.4005 · Cited by 83
Wang, M., Gu, H., Qian, H., Zhu, W., Zhao, C., Zhang, X., Tao, Y., Zhang, L., & Xu, W. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.017 · Cited by 80
Zhang, H., Jin, G., Li, H., Ren, C., Ding, Y., Zhang, Q., Deng, B., Wang, J., Hu, Z., Xu, Y., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr051 · Cited by 76
Molecular basis of therapeutic approaches to gastric cancer
Wu, K., Nie, Y., Guo, C., Chen, Y., Ding, J., & Fan, D. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05753.x · Cited by 75
Schneider, B., Peng, D., Camargo, M. C., Piazuelo, M. B., Sicinschi, L. A., Mera, R. M., Romero–Gallo, J., Delgado, A. G., Bravo, L. E., Wilson, K. T., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25274 · Cited by 75
Circulating MicroRNA in Digestive Tract Cancers
Ichikawa, D., Komatsu, S., Konishi, H., & Otsuji, E. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.008 · Cited by 75
Komuro, A., Yashiro, M., Iwata, C., Morishita, Y., Johansson, E., Matsumoto, Y., Watanabe, A., Aburatani, H., Miyoshi, H., Kiyono, K., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp058 · Cited by 73
Gastric juice microRNA-421 is a new biomarker for screening gastric cancer
Zhang, X., Cui, L., Ye, G., Zheng, T., Song, H., Xia, T., Yu, X., Xiao, B., Le, Y., & Guo, J. (2012) · Tumor Biology · doi:10.1007/s13277-012-0497-x · Cited by 72
Arteaga, C. L. (2007) · Nature Medicine · doi:10.1038/nm0607-675 · Cited by 69
Wong, H., & Yau, T. C. C. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0311 · Cited by 68
Pimentel‐Nunes, P., Gonçalves, N., Boal‐Carvalho, I., Afonso, L. P., Lopes, P., Roncon‐Albuquerque, R., Henrique, R., Moreira‐Dias, L., Leite-Moreira, A. F., & Dinis-Ribeiro, M. J. (2012) · Helicobacter · doi:10.1111/hel.12008 · Cited by 66
Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy
Kim, H. K., Choi, I. J., Kim, C. G., Kim, H. S., Oshima, A., Yamada, Y., Arao, T., Nishio, K., Michalowski, A. M., & Green, J. E. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.87 · Cited by 65
miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer
Wen, D., Li, S., Ji, F., Cao, H., Jiang, W., Zhu, J., & Fang, X. (2013) · Tumor Biology · doi:10.1007/s13277-012-0609-7 · Cited by 63
Saito, Y., Suzuki, H., Imaeda, H., Matsuzaki, J., Hirata, K., Tsugawa, H., Hibino, S., Kanai, Y., Saito, H., & Hibi∥, T. (2012) · International Journal of Cancer · doi:10.1002/ijc.27862 · Cited by 63
MiRNA-199a-3p in Plasma as a Potential Diagnostic Biomarker for Gastric Cancer
Li, C., Li, J. F., Cai, Q., Qiu, Q. Q., Yan, M., Liu, B., & Zhu, Z. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2600-3 · Cited by 63
Clinicopathologic significance of miR-10b expression in gastric carcinoma
Wang, Y., Ye, Z., Zhao, Z., Li, L., Wang, Y., Tao, H., Wang, H., & He, X. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.10.014 · Cited by 61
Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection
Schirrmeister, W., Gnad, T., Wex, T., Higashiyama, S., Wolke, C., Naumann, M., & Lendeckel, U. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.029 · Cited by 59
Bang, Y. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.4_suppl.11 · Cited by 56
Wang, M., Zhang, R., He, J., Qiu, L., Li, J., Wang, Y., Sun, M., Yang, Y., Wang, J., Yang, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031932 · Cited by 55
Self-citationTakeno, A., Takemasa, I., Seno, S., Yamasaki, M., Motoori, M., Miyata, H., Nakajima, K., Takiguchi, S., Fujiwara, Y., Nishida, T., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0854-1 · Cited by 53
Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion
Oh (2009) · Oncology Reports · doi:10.3892/or_00000467 · Cited by 53
Zhou, C., Li, X., Zhang, X., LIU, X., Tan, Z., Yang, C., & Zhang, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1737 · Cited by 46
Li, H., Adachi, Y., Yamamoto, H., Min, Y., Ohashi, H., Ii, M., Arimura, Y., Endo, T., Lee, C., Carbone, D. P., et al. (2011) · Cancer · doi:10.1002/cncr.25893 · Cited by 44
Heindl, S., Eggenstein, E., Keller, S., Kneißl, J., Keller, G., Mutze, K., Rauser, S., Gasteiger, G., Drexler, I., Hapfelmeier, A., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1128-4 · Cited by 43
Pereira, P. S., Teixeira, A., Pinho, S., Ferreira, P. M. P., Fernandes, J., Oliveíra, C., Seruca, R., Suriano, G., & Casares, F. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl093 · Cited by 39
Rizzato, C., Kato, I., Plummer, M., Muñóz, N., Stein, A., Doorn, L. J. V., Franceschi, S., & Canzian, F. (2013) · International Journal of Cancer · doi:10.1002/ijc.28019 · Cited by 35
Epidermal growth factor receptor mutation in gastric cancer
Liu, Z., Liu, L., Li, M., Wang, Z., Feng, L., Zhang, Q., Cheng, S., & Shen, L. (2011) · Pathology · doi:10.1097/pat.0b013e328344e61b · Cited by 35
Mammano, E., Belluco, C., Sciro, M., Mencarelli, R., Agostini, M., Michelotto, M., Marchet, A., & Nitti, D. (2006) · PubMed · Cited by 35
Shi, D., Wang, S., Gu, D., Wu, D., Wang, M., Chu, H., Tong, N., Ma, L., Zhong, D., & Zhang, Z. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1210-6 · Cited by 32
Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer
Zhi, Q., Guo, X., Guo, L., Zhang, R., Jiang, J., Ji, J., Zhang, J., Zhang, J., Chen, X., Cai, Q., et al. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313020013 · Cited by 32
Involvement of Aquaporin 3 in Helicobacter pylori-Related Gastric Diseases
Wang, G., Gao, F., Zhang, W., Chen, J., Wang, T., Zhang, G., & Shen, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049104 · Cited by 27
Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis
Yoshida, T., Kato, J., Maekita, T., Yamashita, S., Enomoto, S., Ando, T., Niwa, T., Deguchi, H., Ueda, K., Inoue, I., et al. (2013) · Gastric Cancer · doi:10.1007/s10120-012-0230-x · Cited by 27
Guo, C.-Y., Xu, X., Wu, J., & Liu, S. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3804 · Cited by 22
Seo, J. H., Kim, H., & Kim, K. H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04687.x · Cited by 15
PG 10.04 Adjuvant chemotherapy: an option for Asian patients only?
Bang, Y.-J. (2012) · European Journal of Cancer · doi:10.1016/s0959-8049(12)70034-5 · Cited by 8
Kohli, M., Oberg, A. L., Mahoney, D. W., Riska, S. M., Zhang, Y., Zenka, R. M., Sahasrabudhe, D. M., Qin, R., Carlson, R. E., & Zhang, S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.30_suppl.11 · Cited by 4
Cited by
Chemotherapy for advanced gastric cancer
Wagner, A. D., Syn, N. L., Moehler, M., Grothe, W., Yong, W. P., Tai, B.-C., Ho, J., & Unverzagt, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004064.pub4 · Cited by 1,299
Giordano, A., & Tommonaro, G. (2019) · Nutrients · doi:10.3390/nu11102376 · Cited by 1,000
Ajani, J. A., Lee, J., Sano, T., Janjigian, Y. Y., Fan, D., & Song, S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.36 · Cited by 594
Self-citationImmunoScore Signature: A Prognostic and Predictive Tool in Gastric Cancer
Jiang, Y., Zhang, Q., Hu, Y., Li, T., Yu, J., Zhao, L., Ye, G., Deng, H., Mou, T., Cai, S., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002116 · Cited by 458
Fibroblast growth factor receptors as treatment targets in clinical oncology
Katoh, M. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0115-y · Cited by 352
Metadata
- Authors
- Wadhwa, R., Song, S., Lee, J.-S., Yao, Y., Wei, Q., & Ajani, J. A.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2013-09-24
- Volume
- 10
- Issue
- 11
- Pages
- 643-655
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W1534578968
- Cited by
- 423
- References
- 175
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.